A Polysaccharide-Based Oral-Vaccine Delivery System and Adjuvant for the Influenza Virus Vaccine
Influenza virus enters the host body through the mucosal surface of the respiratory tract.An efficient immune response at the mucosal site can interfere with virus entry and prevent infection.However, formulating oral vaccines and eliciting an effective mucosal immune response including at respiratory mucosa presents numerous challenges including t